Childbirth
Also known as: Vaginal, Vaginale, Vaginalis
Methodology & AI Transparency ⓘ
Childbirth Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is childbirth? Childbirth is the process of giving birth to a baby.
- 2 Real-world patient consensus: Synonyms for Childbirth (O47.9): Vaginal, Vaginale, Vaginalis (Pediatrics).
- 3 Typical cash cost range: Clinicians assessing Childbirth focus on or congenital embryologic in Childbirth (O47.9: structural variation) and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Childbirth: maintaining WHO / CDC in Childbirth (O47.9: Age-Adjusted Growth Percentiles) within Consistent personal growth curve tracking (O47.9).
Ask our AI Specialists anything about Childbirth
What Is Childbirth?
What is childbirth? Childbirth is the process of giving birth to a baby. It includes labor and delivery of the fetus and the placenta. The placenta is the organ that supplies food and oxygen through the umbilical cord to your fetus during pregnancy . A full-term pregnancy is 40 weeks. Labor usually begins between 37 and 42 weeks of pregnancy . It is how your body prepares to give birth to your baby. Preterm labor can start before 37 completed weeks of pregnancy. It can lead to premature birth. Premature babies may face serious health risks.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Childbirth (O47.9) features or congenital embryologic in Childbirth (O47.9: structural variation). Cross-referenced with NIH MeSH (Labor, Obstetric, Delivery, Obstetric), therapeutic stabilization in pediatrics is verified against Pediatric Hemoglobin & in Childbirth (O47.9: Lead Screen).
Common Symptoms & Clinical Signs
- • Regular contractions start to come closer together
- • Leaking fluid or bleeding from the vagina
- • Presentation of Childbirth (O47.9): acute childhood fever, in Childbirth (O47.9: barking cough, wheezing,)
- • Secondary Childbirth clinical sign: developmental milestone questions in Childbirth (O47.9: across speech, motor)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Childbirth Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | O47.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Children's & Adolescent Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: WHO / CDC in Childbirth (O47.9: Age-Adjusted Growth Percentiles) | Consistent personal growth curve tracking (O47.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Pediatric Hemoglobin & in Childbirth (O47.9: Lead Screen) | Age-normal hemoglobin; blood lead < 3.5 mcg/dL (O47.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Childbirth
Treatment selection for Childbirth depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Childbirth)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Longer-term safety and real-world benefits of baricitinib for eczema in children Baricitinib demonstrated sustained long-term efficacy. The Journal of dermatological treatment • 2024-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39522957 ↗ |
| Can This Approach Help? Inside the Latest Research on Validation of the Novel children Eosinophilic Esophagitis Sign/Symptom This analysis confirmed the reliability and validity of the PESQ-C for evaluating caregiver-observed EoE signs in children patients within a clinical study context. The journal of allergy and clinical immunology. In practice • 2026-04-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41534558 ↗ |
| Can This Approach Help? Inside the Latest Research on Somapacitan in children born small for gestational age: a randomized controlled Somapacitan provides similar efficacy, safety, and tolerability as daily GH in short children born SGA after 52 weeks of treatment. European journal of endocrinology • 2026-03-04 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41782416 ↗ |
Childbirth Patient Community & “People Like Me” Threads
Filter Childbirth community threads and patient logs by age, biological sex, dosage, and treatment duration.